Pediatric Nephrology

, Volume 9, Issue 3, pp 278–281 | Cite as

Vitamin D metabolites in childhood nephrotic syndrome

  • Annick Grymonprez
  • Willem Proesmans
  • Maria Van Dyck
  • Ivo Jans
  • G. Goos
  • Roger Bouillon
Original Article


We measured serum levels of total and ionised calcium, phosphate, intact parathyroid hormone, 25-hydroxyvitamin D [25(OH)D], 1,25-dihydroxyvitamin D [1,25(OH)2D] and the vitamin D binding protein (DBP) in 14 children with idiopathic nephrotic syndrome and 10 healthy, age-matched controls. In all nephrotics serum DBP levels were below the normal range. Serum 25(OH)D was below 7 ng/ml in 10 of 14 nephrotic children and in the low normal range in the remaining 4 patients. The average serum 1,25(OH)2D levels were lower in the nephrotic patients than in the controls. However, free 1,25(OH)2D levels were normal in the nephrotic patients. Both serum 25(OH)D and 1,25(OH)2D correlated positively with the concentration of DBP There was a significant negative correlation between serum DBP levels and the urinary protein excretion and a significant positive correlation between the urinary excretions of DBP and albumin. From this study it can be concluded that the nephrotic child is capable of maintaining appropriate serum concentrations of free calcitriol despite important urinary losses of both substrate and bound calcitriol.

Key words

Nephrotic syndrome Vitamin D 25-hydroxyvitamin D Parathyroid hormone 1,25-dihydroxyvitamin D 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Emerson K, Beckman WW (1945) Calcium metabolism in children with nephrosis. A description of an abnormality in calcium metabolism in children with nephrosis. J Clin Invest 24: 564–572Google Scholar
  2. 2.
    Lim P, Jacob E, Toch EPC, Pwee HS (1977) Calcium and phosphorus metabolism in nephrotic syndrome. Q J Med 46: 327–338Google Scholar
  3. 3.
    Farrington K, Newman SP, Varghese Z, Moorhead JF (1983) Dissociation between calcium and phosphorus absorption in nephrotic syndrome. Clin Sci 65: 437–440Google Scholar
  4. 4.
    McLean FC, Hasting AB (1935) The state of calcium in fluids of the body. J Biol Chem 108: 285–322Google Scholar
  5. 5.
    Lim P, Jacob E, Chil LF, Pwee HS (1976) Serum ionised calcium in the nephrotic syndrome. Q J Med 45: 421–426Google Scholar
  6. 6.
    Scriver W (1929) Observations on the excretion of calcium in two cases of nephrosis treated with parathyroid extract. J Clin Invest 6: 115–125Google Scholar
  7. 7.
    Schmidt-Gayk H, Schmitt W, Grawunder C, Tschope W, Ritz E, Pietsch V, Andrassy K, Bouillon R (1977) 25 hydroxy vitamin D in nephrotic syndrome. Lancet 11: 105–108Google Scholar
  8. 8.
    Barragry JM, Carter ND, Beer M, France AW, Auton JA, Boucher BJ, Cohen RD (1977) Vitamin D metabolism in nephrotic syndrome. Lancet II: 629–632Google Scholar
  9. 9.
    Goldstein DA, Oda Y, Kurokawa K, Massry SG (1977) Blood levels of 25 hydroxy vitamin D in nephrotic syndrome: studies in 26 patients. Ann Intern Med 87: 664–667Google Scholar
  10. 10.
    Colston K, Williams NJ, Cleeve JW (1985) Studies in vitamin D binding protein in the nephrotic syndrome. Clin Chem 31: 718–721Google Scholar
  11. 11.
    Auwerx J, De Keyser L, Bouillon R, De Moor P (1986) Decreased free 1,25 dihydroxycholecalciferol index in patients with the nephrotic syndrome. Nephron 42: 231–235Google Scholar
  12. 12.
    Koenig KG, Lindberg JS, Zerwekh JE, Padalino PK, Cushner HM, Copley JB (1992) Free and total 1,25 dihydroxyvitamin D levels in subjects with renal disease. Kidney Int 41: 161–165Google Scholar
  13. 13.
    Freundlich M, Bourgoignie J, Zillervelo G, Abitbol C, Canterbury J, Strauss J (1986) Calcium and vitamin D metabolism in children with nephrotic syndrome. J Pediatr 108: 383–387Google Scholar
  14. 14.
    Bouillon R, Coopmans W, Degroote DEH, Radoux D, Eliard PH (1990) Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies. Clin Chem 36: 271–276Google Scholar
  15. 15.
    Bouillon R, Van Kerckhove P, De Moor P (1976) Measurement of 25 hydroxyvitamin D3 in serum. Clin Chem 22: 364–368Google Scholar
  16. 16.
    Bouillon R, De Moor P, Bagglioni EG, Uskokovic MR (1980) A radioimmunoassay for 1,25 dihydroxycholecalciferol. Clin Chem 26: 262–268Google Scholar
  17. 17.
    Bouillon R, Van Baelen H, De Moor P (1977) The measurement of vitamin D binding protein in human serum. J Clin Endocrinol Metab 22: 364–368Google Scholar
  18. 18.
    Bouillon R, Van Baelen H (1981) Transport of vitamin D: significance of free and total concentrations of the vitamin D metabolites. Calcif Tissue Int 33: 451–453Google Scholar
  19. 19.
    Bouillon R, Van Assche FA, Van Baelen H, Heyns W, De Moor P (1981) Influence of the vitamin D binding protein on the serum concentration of 1,25-dihydroxyvitamin D. J Clin Invest 67: 589–596Google Scholar
  20. 20.
    Korkor A, Schwarz J, Bergfeld M, Teitelbaum S, Avioli L, Klam S, Slatolpolsky E (1983) Absence of metabolic bone disease in adult patients with the nephrotic syndrome and normal renal function. J Clin Endocrinol Metab 56: 496–500Google Scholar
  21. 21.
    Lambert PW, De Oreao PB, Fu IY, Kaetzel K, Van Alm K, Holliw BW, Roos BA (1982) Urinary and plasma vit D metabolites in the nephrotic syndrome. Metab Bone Dis Relat Res 4: 7–15Google Scholar

Copyright information

© IPNA 1995

Authors and Affiliations

  • Annick Grymonprez
    • 1
  • Willem Proesmans
    • 1
  • Maria Van Dyck
    • 1
  • Ivo Jans
    • 2
  • G. Goos
    • 1
  • Roger Bouillon
    • 2
  1. 1.Department of PaediatricsUniversity of LeuvenLeuvenBelgium
  2. 2.Laboratory for Experimental Medicine and EndocrinologyUniversity of LeuvenLeuvenBelgium

Personalised recommendations